Lupron

DRUG7 trials

Sponsors

Radiation Therapy Oncology Group, Schiffler Cancer Center, Memorial Sloan Kettering Cancer Center, Pharmatech, Icahn School of Medicine at Mount Sinai

Conditions

High-risk Prostate CancerLeukemiaMultiple MyelomaMyelodysplastic SyndromeNon-Hodgkin's LymphomaObesity, MorbidProstate AdenocarcinomaProstate Cancer

Phase 2

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Active, not recruitingNCT01746849

Memorial Sloan Kettering Cancer CenterLeukemia, Multiple Myeloma, Myelodysplastic Syndrome +1

Start: 2012-12-31End: 2026-12-31Updated: 2026-01-07

A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

CompletedNCT03572387

Icahn School of Medicine at Mount SinaiProstate Cancer, Prostate Neoplasms, Prostatic Neoplasms

Start: 2018-08-20End: 2022-07-08Updated: 2024-04-30

Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer

WithdrawnNCT04331717

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsObesity, Morbid, Prostate Adenocarcinoma

Start: 2020-11-16End: 2023-12-31Updated: 2022-05-02

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

RecruitingNCT07027124

Icahn School of Medicine at Mount SinaiHigh-risk Prostate Cancer, Prostate Cancer

Start: 2026-03-19End: 2031-05-02Target: 40Updated: 2026-03-19

Phase 3

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

CompletedNCT00002597

Radiation Therapy Oncology GroupProstate Cancer

Start: 1994-10-31End: 2018-05-14Updated: 2018-06-14

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

TerminatedNCT00243646

Schiffler Cancer CenterProstate Cancer

Start: 2004-08-31End: 2009-07-31Updated: 2016-04-14

Phase 4

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

TerminatedNCT02749825

PharmatechProstate Cancer

Start: 2002-09-30End: 2006-07-31Updated: 2016-04-25

Related Papers

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer

NEJM Evidence2023-06-29101 citations

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.

2023-01-285 citations

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

2011-07-01475 citations